Pharmacogenetic risk factors for altered bone mineral density and body composition in pediatric acute lymphoblastic leukemia

Haematologica

Volumn 95, Issue 5, 2010, Pages 752-759

  te Winkel, Mariël L ^a   van Beek, Robert D ^a   Keizer Schrama, Sabine M P F de Muinck ^a   Uitterlinden, André G ^b   Hop, Wim C J ^b   Pieters, Rob ^a   van den Heuvel Eibrink, Marry M ^a  

^a SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Acute lymphoblastic leukemia; Cdx 2 GATA; Pharmacogenetic risk factors

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA 1; DEXAMETHASONE; ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID RECEPTOR; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

5' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BODY COMPOSITION; BONE DENSITY; CHILD; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FRACTURE; HAPLOTYPE; HETEROZYGOTE; HUMAN; LEAN BODY WEIGHT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PEDIATRICS; PHARMACOGENETICS; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; WEIGHT GAIN;

ADOLESCENT; BODY COMPOSITION; BONE DENSITY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEXAMETHASONE; ESTROGEN RECEPTOR ALPHA; FEMALE; FOLLOW-UP STUDIES; GENETIC VARIATION; HUMANS; INFANT; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROSPECTIVE STUDIES; RECEPTORS, CALCITRIOL; RISK FACTORS;

EID: 77952315199     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2009.016303     Document Type: Article

References (50)

1. Veerman AJ, Hahlen K, Kamps WA, Van Leeuwen EF, De Vaan GA, Solbu G, et al. High cure rate with a moderately intensive treatment regimen in non-high-risk child-hood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group. J Clin Oncol. 1996;14(3):911-8.
2. Boot AM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density in children with acute lymphoblastic leukaemia. Eur J Cancer. 1999;35(12):1693-7.
3. Crofton PM, Ahmed SF, Wade JC, Stephen R, Elmlinger MW, Ranke MB, et al. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia. J Clin Endocrinol Metab. 1998; 83(9):3121-9.
4. van der Sluis IM, van den Heuvel-Eibrink MM, Hahlen K, Krenning EP, de Muinck Keizer-Schrama SM. Altered bone mineral density and body composition, and increased fracture risk in childhood acute lymphoblastic leukemia. J Pediatr. 2002; 141(2):204-10.
5. Reid IR. Glucocorticoid osteoporosis- mechanisms and management. Eur J Endocrinol. 1997;137(3):209-17.
6. Ragab AH, Frech RS, Vietti TJ. Osteoporotic fractures secondary to methotrexate therapy of acute leukemia in remission. Cancer. 1970;25(3):580-5.
7. Alvarez-Hernandez D, Naves M, Diaz-Lopez JB, Gomez C, Santamaria I, Cannata-Andia JB. Influence of polymorphisms in VDR and COLIA1 genes on the risk of osteoporotic fractures in aged men. Kidney Int Suppl. 2003;(85):S14-8.
8. Fang Y, van Meurs JB, Bergink AP, Hofman A, van Duijn CM, van Leeuwen JP, et al. Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res. 2003;18(9): 1632-41.
9. Fang Y, van Meurs JB, d'Alesio A, Jhamai M, Zhao H, Rivadeneira F, et al. Promoter and 3'-untranslated-region haplotypes in the vitamin d receptor gene predispose to osteoporotic fracture: the Rotterdam study. Am J Hum Genet. 2005;77(5):807-23.
10. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, et al. Prediction of bone density from vitamin D receptor alle- les. Nature. 1994;367(6460):284-7.
11. Tokita A, Matsumoto H, Morrison NA, Tawa T, Miura Y, Fukamauchi K, et al. Vitamin D receptor alleles, bone mineral density and turnover in premenopausal Japanese women. J Bone Miner Res. 1996; 11(7):1003-9.
12. Uitterlinden AG, Pols HA, Burger H, Huang Q, Van Daele PL, Van Duijn CM, et al. A large-scale population-based study of the association of vitamin D receptor gene polymorphisms with bone mineral density. J Bone Miner Res. 1996;11(9):1241-8.
13. Gong G, Stern HS, Cheng SC, Fong N, Mordeson J, Deng HW, et al. The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int. 1999;9(1):55-64.
14. Lorentzon M, Lorentzon R, Nordstrom P. Vitamin D receptor gene polymorphism is related to bone density, circulating osteocalcin, and parathyroid hormone in healthy adolescent girls. J Bone Miner Metab. 2001;19(5):302-7.
15. Sainz J, Van Tornout JM, Loro ML, Sayre J, Roe TF, Gilsanz V. Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med. 1997;337(2):77-82.
16. Baroncelli GI, Federico G, Bertelloni S, Ceccarelli C, Cupelli D, Saggese G. Vitamin-D receptor genotype does not predict bone mineral density, bone turnover, and growth in prepubertal children. Horm Res. 1999;51(3):150-6.
17. van der Sluis IM, de Muinck Keizer-Schrama SM, Krenning EP, Pols HA, Uitterlinden AG.; Vitamin D receptor gene polymorphism predicts height and bone size, rather than bone density in children and young adults. Calcif Tissue Int. 2003;73(4):332-8.
18. Grundberg E, Brandstrom H, Ribom EL, Ljunggren O, Mallmin H, Kindmark A. Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol. 2004;150(3):323-8.
19. Garnero P, Borel O, Grant SF, Ralston SH, Delmas PD. Collagen Ialpha1 Sp1 polymorphism, bone mass, and bone turnover in healthy French premenopausal women: the OFELY study. J Bone Miner Res. 1998;13(5):813-7.
20. Mann V, Hobson EE, Li B, Stewart TL, Grant SF, Robins SP, et al. A COL1A1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest. 2001;107(7):899-907.
21. Uitterlinden AG, Burger H, Huang Q, Yue F, McGuigan FE, Grant SF, et al. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med. 1998;338(15):1016-21.
22. Suuriniemi M, Kovanen V, Mahonen A, Alen M, Wang Q, Lyytikainen A, et al. COL1A1 Sp1 polymorphism associates with bone density in early puberty. Bone. 2006;39(3):591-7.
23. van der Sluis IM, de Muinck Keizer-Schrama SM, Pols HA, Lequin MH, Krenning; EP, Uitterlinden AG. Collagen Ialpha1 polymorphism is associated with bone characteristics in Caucasian children and young adults. Calcif Tissue Int. 2002;71(5):393-9.
24. Berg JP, Lehmann EH, Stakkestad JA, Haug E, Halse J. The Sp1 binding site polymorphism in the collagen type I alpha 1 (COLIA1) gene is not associated with bone mineral density in healthy children, adolescents, and young adults. Eur J Endocrinol. 2000;143(2):261-5.
25. Willing MC, Torner JC, Burns TL, Janz KF, Marshall T, Gilmore J, et al. Gene polymorphisms, bone mineral density and bone mineral content in young children: the Iowa Bone Development Study. Osteoporos Int. 2003;14(8):650-8.
26. Albagha OM, McGuigan FE, Reid DM, Ralston SH. Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res. 2001;16(1):128-34.
27. Ioannidis JP, Ralston SH, Bennett ST, Brandi ML, Grinberg D, Karassa FB, et al. Differential genetic effects of ESR1 gene polymorphisms on osteoporosis outcomes. Jama. 2004;292(17):2105-14.
28. van Meurs JB, Schuit SC, Weel AE, van der Klift M, Bergink AP, Arp PP, et al. Association of 5' estrogen receptor alpha gene polymorphisms with bone mineral density, vertebral bone area and fracture risk. Hum Mol Genet. 2003;12(14):1745-54.
29. Boot AM, van der Sluis IM, de Muinck Keizer-Schrama SM, van Meurs JB, Krenning EP, Pols HA, et al. Estrogen recep-tor alpha gene polymorphisms and bone mineral density in healthy children and young adults. Calcif Tissue Int. 2004;74(6):495-500.
30. Tobias JH, Steer CD, Vilarino-Guell C, Brown MA. Effect of an estrogen receptor- alpha intron 4 polymorphism on fat mass in 11-year-old children. J Clin Endocrinol Metab. 2007;92(6):2286-91.
31. van Rossum EF, Koper JW, van den Beld AW, Uitterlinden AG, Arp P, Ester W, et al. Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin Endocrinol. (Oxf). 2003;59(5):585-92.
32. Huizenga NA, Koper JW, De Lange P, Pols HA, Stolk RP, Burger H, et al. A polymorphism in the glucocorticoid receptor gene may be associated with and increased sensitivity to glucocorticoids in vivo. J Clin Endocrinol Metab. 1998;83(1):144-51.
33. van Schoor NM, Dennison E, Lips P, Uitterlinden AG, Cooper C. Serum fasting cortisol in relation to bone, and the role of genetic variations in the glucocorticoid receptor. Clin Endocrinol (Oxf). 2007; 67(6):871-8.
34. Rosmond R, Chagnon YC, Holm G, Chagnon M, Perusse L, Lindell K, et al. A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamicpituitary-adrenal axis. Obes Res. 2000; 8(3):211-8.
35. Veerman AJP, Kamps WA, van den Berg-de Ruiter E, van den Berg H, Bökkerink JPM, Bruin MCA, et al. Dexamethasone based therapy in childhood acute lymphoblastic leukaemia with favourable event-free survival: results of the Dutch Childhood Oncology Group (DCOG) ALL-9 protocol (1997-2004). The Lancet Oncology 2009; 10(10):957-66.
36. Arai H, Miyamoto KI, Yoshida M, Yamamoto H, Taketani Y, Morita K, et al. The polymorphism in the caudal-related homeodomain protein Cdx-2 binding element in the human vitamin D receptor gene. J Bone Miner Res. 2001;16(7):1256-64.
37. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH. Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet. 1996;14(2):203-5.
38. Tissing WJ, Meijerink JP, den Boer ML, Brinkhof B, van Rossum EF, van Wering ER, et al. Genetic variations in the glucocorticoid receptor gene are not related to gluco-corticoid resistance in childhood acute lym-phoblastic leukemia. Clin Cancer Res. 2005;11(16):6050-6.
39. Fredriks AM, van Buuren S, Wit JM, Verloove-Vanhorick SP. Body index measurements in 1996-7 compared with 1980. Arch Dis Child. 2000;82(2):107-12.
40. Fredriks AM, van Buuren S, Burgmeijer RJ, Meulmeester JF, Beuker RJ, Brugman E, et al. Continuing positive secular growth change in The Netherlands 1955-1997. Pediatr Res. 2000;47(3):316-23.
41. Kroger H, Vainio P, Nieminen J, Kotaniemi A. Comparison of different models for interpreting bone mineral density measurements using DXA and MRI technology. Bone. 1995;17(2):157-9.
42. van der Sluis IM, de Ridder MA, Boot AM, Krenning EP, de Muinck Keizer-Schrama SM. Reference data for bone density and body composition measured with dual energy x ray absorptiometry in white children and young adults. Arch Dis Child. 2002 Oct;87(4):341-7; discussion 341-7.
43. Kemper HC, Bakker I, Twisk JW, van Mechelen W. Validation of a physical activity questionnaire to measure the effect of mechanical strain on bone mass. Bone. 2002;30(5):799-804.
44. Angus RM, Sambrook PN, Pocock NA, Eisman JA. A simple method for assessing calcium intake in Caucasian women. J Am Diet Assoc. 1989;89(2):209-14.
45. Roodnat JI, van Gurp EA, Mulder PG, van Gelder T, de Rijke YB, de Herder WW, et al. High pretransplant parathyroid hormone levels increase the risk for graft failure after renal transplantation. Transplantation. 2006;82(3):362-7.
46. McCarty MF, Thomas CA. PTH excess may promote weight gain by impeding catecholamine-induced lipolysis-implications for the impact of calcium, vitamin D, and alcohol on body weight. Med Hypotheses. 2003;61(5-6):535-42.
47. Fox CS, Yang Q, Cupples LA, Guo CY, Atwood LD, Murabito JM, et al. Sex-specific association between estrogen receptor- alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab. 2005;90(11):6257-62.
48. Ferrari SL, Rizzoli R, Slosman DO, Bonjour JP. Do dietary calcium and age explain the controversy surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms? J Bone Miner Res. 1998;13(3):363-70.
49. Ho YV, Briganti EM, Duan Y, Buchanan R, Hall S, Seeman E. Polymorphism of the vitamin D receptor gene and corticosteroid- related osteoporosis. Osteoporos Int. 1999;9(2):134-8.
50. Salamone LM, Glynn NW, Black DM, Ferrell RE, Palermo L, Epstein RS, et al. Determinants of premenopausal bone mineral density: the interplay of genetic and lifestyle factors. J Bone Miner Res. 1996;11(10):1557-65.